Paik, Chang H. External Entity

Publications

Sort by

Selected publications

  • 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.  Proceedings of the National Academy of Sciences of the United States of America2015 Academic Article GET IT
    Times cited: 7

Other